Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement.
Endocrine Unit, Department of Clinical and Experimental Medicine, University of Insubria, Ospedale di Circolo, Viale Borri, 57, 21100, Varese, Italy. luigi.bartalena@uninsubria.it.
L
L
Bartalena
Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy.
P E
PE
Macchia
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
C
C
Marcocci
Department of Clinical Sciences and Community Health, Graves' Orbitopathy Center, Fondazione Ca' Granda IRCCS and University of Milan, Milan, Italy.
M
M
Salvi
Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
F
F
Vermiglio
D032921:Consensus; D006111:Graves Disease / Q000188:drug therapy* / Q000601:surgery*; D049970:Graves Ophthalmopathy / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D007558:Italy; D017410:Practice Guidelines as Topic / Q000592:standards*; D012955:Societies, Medical / Q000592:standards*
Antithyroid drugs; Glucocorticoids; Graves’ disease; Graves’ orbitopathy; Radioiodine; Thionamides; Thyroidectomy